Cochlear Limited (OTCMKTS:CHEOY - Get Free Report) saw a large decrease in short interest in the month of February. As of February 28th, there was short interest totalling 100 shares, a decrease of 97.6% from the February 13th total of 4,100 shares. Based on an average daily volume of 54,700 shares, the days-to-cover ratio is currently 0.0 days. Approximately 0.0% of the company's shares are sold short.
Analysts Set New Price Targets
Separately, The Goldman Sachs Group assumed coverage on shares of Cochlear in a research report on Thursday, January 16th. They issued a "neutral" rating on the stock.
Read Our Latest Research Report on Cochlear
Cochlear Stock Performance
Cochlear stock traded up $1.76 during midday trading on Friday, reaching $83.65. The stock had a trading volume of 21,824 shares, compared to its average volume of 15,954. Cochlear has a 52-week low of $77.93 and a 52-week high of $115.85. The company has a fifty day moving average of $91.12 and a 200 day moving average of $94.50.
Cochlear Increases Dividend
The company also recently disclosed a dividend, which will be paid on Tuesday, April 29th. Investors of record on Friday, March 21st will be given a $0.6165 dividend. This is a positive change from Cochlear's previous dividend of $0.14. The ex-dividend date of this dividend is Friday, March 21st.
Cochlear Company Profile
(
Get Free Report)
Cochlear Limited provides implantable hearing solutions for children and adults worldwide. It offers cochlear implant systems, sound processor upgrades, bone conduction systems, accessories, and other products. Cochlear Limited was founded in 1981 and is headquartered in Sydney, Australia.
Featured Articles
Before you consider Cochlear, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Cochlear wasn't on the list.
While Cochlear currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
If a company's CEO, COO, and CFO were all selling shares of their stock, would you want to know? MarketBeat just compiled its list of the twelve stocks that corporate insiders are abandoning. Complete the form below to see which companies made the list.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
